ALEXANDER MAZEKINA TAIRA: Open Payments
NPI 1982061214 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,926 in 87 payments from 11 companies in 2025. Trend: 2023 $1,939 · 2024 $2,394 · 2025 $3,926
Food & beverage: $3,917Education: $9
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $1,043 |
| ABBVIE INC. | 31 | $1,020 |
| Madrigal Pharmaceuticals | 10 | $904 |
| Aimmune Therapeutics, Inc. | 7 | $286 |
| Phathom Pharmaceuticals, Inc. | 4 | $169 |
| Ardelyx, Inc. | 2 | $152 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $150 |
| Novo Nordisk Inc | 2 | $138 |
| Braintree Laboratories, Inc. | 2 | $31 |
| VIVUS LLC | 1 | $23 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, ZENPEP, RINVOQ, VOQUEZNA, LINZESS, IBSRELA.
Industry payments across FL — which companies pay providers there.
